Management of papillary thyroid cancer: An overview for the primary care physician

Paulino Tallón de Lara; Elizabeth H. Holt; Glenda G. Callender; David Cheng; Hari A. Deshpande

Management of papillary thyroid cancer: An overview for the primary care physician

Paulino Tallón de Lara
, Elizabeth H. Holt
, Glenda G. Callender
, David Cheng
, Hari A. Deshpande

Research output: Contribution to journal › Review article › peer-review

1 Scopus citations

Abstract

Objective: To review management of papillary thyroid cancer. Methods: Review of the literature. Results: Papillary thyroid cancer is the most common endocrine malignancy. The standard treatment for papillary thyroid cancer is thyroidectomy. Adjuvant therapy includes lifelong thyroid-stimulating hormone suppression and radioiodine therapy. Local recurrence is common and is normally treated with surgery and/or radioiodine. Metastatic radioiodine-resistant disease is a more infrequent event. Conclusion: The incidence of papillary thyroid cancer is rapidly increasing. Surgery remains the cornerstone of treatment.

Original language	English
Pages (from-to)	233-240
Number of pages	8
Journal	Journal of Clinical Outcomes Management
Volume	21
Issue number	5
State	Published - May 2014
Externally published	Yes

Cite this

@article{a3bf9640d19940d5b929ee08288707f5,

title = "Management of papillary thyroid cancer: An overview for the primary care physician",

abstract = "Objective: To review management of papillary thyroid cancer. Methods: Review of the literature. Results: Papillary thyroid cancer is the most common endocrine malignancy. The standard treatment for papillary thyroid cancer is thyroidectomy. Adjuvant therapy includes lifelong thyroid-stimulating hormone suppression and radioiodine therapy. Local recurrence is common and is normally treated with surgery and/or radioiodine. Metastatic radioiodine-resistant disease is a more infrequent event. Conclusion: The incidence of papillary thyroid cancer is rapidly increasing. Surgery remains the cornerstone of treatment.",

author = "\{Tall{\'o}n de Lara\}, Paulino and Holt, \{Elizabeth H.\} and Callender, \{Glenda G.\} and David Cheng and Deshpande, \{Hari A.\}",

year = "2014",

month = may,

language = "English",

volume = "21",

pages = "233--240",

journal = "Journal of Clinical Outcomes Management",

issn = "1079-6533",

publisher = "Frontline Medical Communications Inc.",

number = "5",

}

TY - JOUR

T1 - Management of papillary thyroid cancer

T2 - An overview for the primary care physician

AU - Tallón de Lara, Paulino

AU - Holt, Elizabeth H.

AU - Callender, Glenda G.

AU - Cheng, David

AU - Deshpande, Hari A.

PY - 2014/5

Y1 - 2014/5

N2 - Objective: To review management of papillary thyroid cancer. Methods: Review of the literature. Results: Papillary thyroid cancer is the most common endocrine malignancy. The standard treatment for papillary thyroid cancer is thyroidectomy. Adjuvant therapy includes lifelong thyroid-stimulating hormone suppression and radioiodine therapy. Local recurrence is common and is normally treated with surgery and/or radioiodine. Metastatic radioiodine-resistant disease is a more infrequent event. Conclusion: The incidence of papillary thyroid cancer is rapidly increasing. Surgery remains the cornerstone of treatment.

AB - Objective: To review management of papillary thyroid cancer. Methods: Review of the literature. Results: Papillary thyroid cancer is the most common endocrine malignancy. The standard treatment for papillary thyroid cancer is thyroidectomy. Adjuvant therapy includes lifelong thyroid-stimulating hormone suppression and radioiodine therapy. Local recurrence is common and is normally treated with surgery and/or radioiodine. Metastatic radioiodine-resistant disease is a more infrequent event. Conclusion: The incidence of papillary thyroid cancer is rapidly increasing. Surgery remains the cornerstone of treatment.

UR - https://www.scopus.com/pages/publications/84904600470

M3 - Review article

AN - SCOPUS:84904600470

SN - 1079-6533

VL - 21

SP - 233

EP - 240

JO - Journal of Clinical Outcomes Management

JF - Journal of Clinical Outcomes Management

IS - 5

ER -

Management of papillary thyroid cancer: An overview for the primary care physician

Abstract

Fingerprint

Cite this